Requip CR tablets 2mg, manufactured by GlaxoSmithKline, contain Ropinirole Hydrochloride. This controlled-release formulation, with YJ code 1169013G1022 and a standard of 2mg per tablet, is primarily used for the treatment of Parkinson’s disease.
Requip CR tablets 2mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
